Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 6136 AL 6150

Alzheimer's disease: a review of recent developments

Salawu FK, Umar JT, Olokoba AB.

Ann Afr Med. 2011 Apr-Jun;10(2):73-9. doi: 10.4103/1596-3519.82057.

Short-term hormone therapy with transdermal estradiol improves cognition for postmenopausal women with Alzheimer's disease: results of a randomized controlled trial

Wharton W, Baker LD, Gleason CE, Dowling M, Barnet JH, Johnson S, Carlsson C, Craft S, Asthana S.

J Alzheimers Dis. 2011;26(3):495-505. doi: 10.3233/JAD-2011-110341.

A randomized controlled trial of high-dose vitamin D2 followed by intranasal insulin in Alzheimer's disease

Stein MS, Scherer SC, Ladd KS, Harrison LC.

J Alzheimers Dis. 2011;26(3):477-84. doi: 10.3233/JAD-2011-110149.

Evaluation of the regional cerebral blood flow changes during long-term donepezil therapy in patients with Alzheimer's disease using 3DSRT

Kimura N, Kumamoto T, Masuda T, Hanaoka T, Okazaki T, Arakawa R.

J Neuroimaging. 2012 Jul;22(3):299-304. doi: 10.1111/j.1552-6569.2011.00612.x. Epub 2011 Jun 23.

New developments in the search for a cure

Alkon DL.

W V Med J. 2011 May-Jun;107(3):10-3.

Maintaining physical fitness and function in Alzheimer's disease: a pilot study

Yu F, Savik K, Wyman JF, Bronas UG.

Am J Alzheimers Dis Other Demen. 2011 Aug;26(5):406-12. doi: 10.1177/1533317511414861. Epub 2011 Jul 12.

A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease

Sano M, Bell KL, Galasko D, Galvin JE, Thomas RG, van Dyck CH, Aisen PS.

Neurology. 2011 Aug 9;77(6):556-63. doi: 10.1212/WNL.0b013e318228bf11. Epub 2011 Jul 27.

Nanomedicine in the European Commission policy for nanotechnology

Gabellieri C, Frima H.

Nanomedicine. 2011 Oct;7(5):519-20. doi: 10.1016/j.nano.2011.07.003. Epub 2011 Jul 28.

Longitudinal changes of fractional anisotropy in Alzheimer's disease patients treated with galantamine: a 12-month randomized, placebo-controlled, double-blinded study

Likitjaroen Y, Meindl T, Friese U, Wagner M, Buerger K, Hampel H, Teipel SJ.

Eur Arch Psychiatry Clin Neurosci. 2012 Jun;262(4):341-50. doi: 10.1007/s00406-011-0234-2. Epub 2011 Aug 5.

Alzheimer's care at home: a focus on caregivers strain

Varela G, Varona L, Anderson K, Sansoni J.

Prof Inferm. 2011 Apr-Jun;64(2):113-7.

Six-month walking program changes cognitive and ADL performance in patients with Alzheimer

Venturelli M, Scarsini R, Schena F.

Am J Alzheimers Dis Other Demen. 2011 Aug;26(5):381-8. doi: 10.1177/1533317511418956. Epub 2011 Aug 17.

Sexuality in institutionalized elderly persons: a systematic review of argument-based ethics literature

Mahieu L, Gastmans C.

Int Psychogeriatr. 2012 Mar;24(3):346-57. doi: 10.1017/S1041610211001542. Epub 2011 Aug 24.

Long-term effects of galantamine on cognitive function in Alzheimer's disease: a large-scale international retrospective study

Kavanagh S, Van Baelen B, Schäuble B.

J Alzheimers Dis. 2011;27(3):521-30. doi: 10.3233/JAD-2011-110417.

Attenuation of neuropsychiatric symptoms and caregiver burden in Alzheimer's disease by motor intervention: a controlled trial

Stella F, Canonici AP, Gobbi S, Galduroz RF, Cação Jde C, Gobbi LT.

Clinics (Sao Paulo). 2011;66(8):1353-60. doi: 10.1590/s1807-59322011000800008.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias